Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Jan 2026 for Milestone Pharmaceuticals Inc.. Read the official filing
Filing timeline
BuySaleDavid Bharucha
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -29.0%Entry US$4.51 · Close at T+365 US$3.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Bharucha: trading record in brief
This profile gathers the share dealings of David Bharucha in Milestone Pharmaceuticals Inc. Over a trading history stretching from 1 December 2022 to 12 December 2025, the count stands at 3 filings.
The open-market record is one-sided, with 1 purchase worth €14k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants.
The newest entry dates from 28 January 2026: a share grant, in Milestone Pharmaceuticals Inc. The clock since the last published purchase (5 December 2022) now reads 1,414 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Bharucha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
100,000 sharesCommon SharesSEC:0001910985-26-000003:0
53,333 sharesCommon SharesSEC:0001415889-25-019773:0
3,000 shares@ US$4.86100.0% of flowCommon SharesSEC:0001209191-22-059720:0
Canonical exit: 1 Mar 2023 (T+90)
3 of 3 declarations
